Cargando…

Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study

Interindividual variability in analgesic response is at least partly due to well-characterized polymorphisms that are associated with opioid dosing and adverse outcomes. The Clinical Pharmacogenetics Implementation Consortium (CPIC) has put forward recommendations for the CYP2D6 phenotype, but the l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agulló, Laura, Aguado, Isidro, Muriel, Javier, Margarit, César, Gómez, Alba, Escorial, Mónica, Sánchez, Astrid, Fernández, Alicia, Peiró, Ana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341655/ https://www.ncbi.nlm.nih.gov/pubmed/37445931 http://dx.doi.org/10.3390/ijms241310754

Ejemplares similares

Sex-Differences in Pain and Opioid Use Disorder Management: A Cross-Sectional Real-World Study
por: Escorial, Mónica, et al.
Publicado: (2022)

Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain
por: Agulló, Laura, et al.
Publicado: (2023)

Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences
por: Muriel, Javier, et al.
Publicado: (2023)

Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
por: Barrachina, Jordi, et al.
Publicado: (2022)

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

Codeine and Tramadol Use in Athletes: A Potential for Abuse
por: Zandonai, Thomas, et al.
Publicado: (2021)

Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study
por: Barrachina, Jordi, et al.
Publicado: (2022)

Celecoxib pharmacogenetics and pediatric adenotonsillectomy: a double-blinded randomized controlled study
por: Murto, Kimmo, et al.
Publicado: (2015)

Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders
por: Burns, Jamie A., et al.
Publicado: (2019)

A brief review of the genetics and pharmacogenetics of opioid use disorders
por: Berrettini, Wade
Publicado: (2017)

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial
por: Pérez, Víctor, et al.
Publicado: (2017)

Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study
por: Batinic, Ana, et al.
Publicado: (2023)

Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
por: Verbelen, M, et al.
Publicado: (2017)

Endothelial nitric oxide synthase gene polymorphisms and erectile dysfunction in chronic pain
por: Segura, Ana, et al.
Publicado: (2019)

Patient Perceptions and Potential Utility of Pharmacogenetic Testing in Chronic Pain Management and Opioid Use Disorder in the Camden Opioid Research Initiative
por: Kusic, Dara, et al.
Publicado: (2022)

Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives
por: García-González, Xandra, et al.
Publicado: (2023)

Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics
por: Thompson, Miles D., et al.
Publicado: (2017)

Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder
por: Crist*, Richard. C., et al.
Publicado: (2018)

In between Opioid Crisis and the Need to Treat Pain, where do we Stand?
por: Ionescu, Daniela, et al.
Publicado: (2022)

Rising Racial Disparities in Opioid Mortality and Undertreatment of Opioid Use Disorder and Mental Health Comorbidities in Virginia
por: Britz, Jacqueline B., et al.
Publicado: (2023)

Postoperative analgesia and opioid use following hip arthroscopy with ultrasound-guided quadratus lumborum block: a randomized controlled double-blind trial
por: Yuan, Liangjing, et al.
Publicado: (2020)

Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy
por: Virgili Manrique, Anna C., et al.
Publicado: (2022)

Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report
por: Jessop, Jayson P., et al.
Publicado: (2023)

Clinical Relevance of Pharmacogenetics in Serotonin Syndrome
por: Pandya, Dehuti, et al.
Publicado: (2020)

iGMDR: Integrated Pharmacogenetic Resource Guide to Cancer Therapy and Research
por: Chen, Xiang, et al.
Publicado: (2020)

Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Pharmacogenetics of Lethal Opioid Overdose: Review of Current Evidence and Preliminary Results from a Pilot Study
por: Magarbeh, Leen, et al.
Publicado: (2023)

Cancer pharmacogenetics
por: Marsh, S, et al.
Publicado: (2004)

Experimental Pharmacogenetics
por: Lubs, Herbert A.
Publicado: (1964)

Pharmacogenetics of Anticoagulants
por: Rane, Anders, et al.
Publicado: (2010)

Pharmacogenetics of osteoporosis
por: Marini, Francesca, et al.
Publicado: (2010)

The pharmacogenetics of imatinib
por: Dulucq, Stéphanie, et al.
Publicado: (2010)

Pharmacogenetics of Antidepressants
por: Crisafulli, Concetta, et al.
Publicado: (2011)

Pharmacogenetics in the clinic
por: Guchelaar, H.-J.
Publicado: (2013)

Pharmacogenetics of Cannabinoids
por: Hryhorowicz, Szymon, et al.
Publicado: (2017)

Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019)

Psychosis and Comorbid Opioid Use Disorder: Characteristics and Outcomes in Opioid Substitution Therapy
por: Lamont, Rachel, et al.
Publicado: (2020)

Pharmacogenetics of Pediatric Asthma: Current Perspectives
por: Perez-Garcia, Javier, et al.
Publicado: (2020)

Effects of opioid receptor stimulation and blockade on touch pleasantness: a double-blind randomised trial
por: Løseth, Guro E, et al.
Publicado: (2019)

Anxiety Treatment of Opioid Dependent Patients with Buprenorphine: A Randomized, Double-blind, Clinical Trial
por: Ahmadi, Jamshid, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6lsce6h6o7dt0bi4pdusank79n